Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

DYNAMIC - Circulating Tumor DNA to decide Adjuvant Chemo in Stage II Colon Cancer

Error-corrected deep targeted sequencing of circulating cell-free DNA from colorectal cancer patients for sensitive detection of circulating tumor DNA

Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy

Highly Sensitive Circulating Tumor DNA Assay Aids Clinical

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy In, 50% OFF

Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system

Locally performed postoperative circulating tumour DNA testing

Heterogeneity in precision oncology

PDF) Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): Study protocol for a trial within a cohort study

PDF] The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

Cancers, Free Full-Text

Prognostic value of circulating tumor DNA in pancreatic cancer: a

Oncology Data Advisor - Guiding Colorectal Cancer Treatment Decisions Using ctDNA

Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer

Locally performed postoperative circulating tumour DNA testing performed during routine clinical care to predict recurrence of colorectal cancer - Cohen - 2023 - ANZ Journal of Surgery - Wiley Online Library